Retraction
Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis
Paper Information
Record ID:
66327
Journal:
Publication Date:
November 07, 2018
Retraction Date:
December 28, 2024
(<1 year years ago)
Subjects:
Institutions:
- Department of Biochemistry & Clinical laboratory, Faculty of medicine, Tabriz University of Medical Sciences, Tabriz, Iran
- Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
- Hematology & Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Country:
🇮🇷 IranArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.biopha.2024.117775Citations (21)
21
Total Citations2
Post-Retraction(9.5%)
18
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
70
Days since retraction (latest)
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Mar 2025
70 days after retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Feb 2025
35 days after retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Jun 2024
189 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Oct 2023
454 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Nov 2022
788 days before retraction
CPEB2 m6A methylation regulates blood–tumor barrier permeability by regulating splicing factor SRSF5 stability
Mengyang Zhang, Chunqing Yang, Xuelei Ruan et al. (10 authors)
Communications Biology
Open Access
Published: Sep 2022
24 citations
24 citations
845 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Jul 2022
908 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Mar 2022
1019 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Dec 2021
1103 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Nov 2021
1152 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Jul 2021
1276 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Apr 2021
1355 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Feb 2021
1417 days before retraction
Harnessing WYE-132 as an inhibitor of the mTOR signaling enriches the cytotoxicity effect of vinblastine in B16F10 melanoma cancer cells
Fatemeh Khaki‐Khatibi, Mahdi Zeinali, Bahman Ramezani et al. (6 authors)
Process Biochemistry
Published: Sep 2020
19 citations
19 citations
1577 days before retraction
Role of STAT3 signaling pathway in breast cancer
Jiahui Ma, Li Qin, Xia Li
Cell Communication and Signaling
Open Access
Published: Feb 2020
347 citations
347 citations
1765 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Jan 2020
1808 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Nov 2019
1863 days before retraction
Adjuvant therapy with γ‐tocopherol‐induce apoptosis in HT‐29 colon cancer via cyclin‐dependent cell cycle arrest mechanism
Roya Bazzaz, Hossain Bijanpour, Seyed Mohammadbagher Pirouzpanah et al. (5 authors)
Journal of Biochemical and Molecular Toxicology
Published: Oct 2019
8 citations
8 citations
1910 days before retraction
Paper citing Adjuvant therapy with stattic enriches the anti-pr...
Unknown Authors
Unknown Journal
Published: Jun 2019
2037 days before retraction
Naringenin-loaded nano-structured lipid carrier fortifies oxaliplatin-dependent apoptosis in HT-29 cell line
Sina Raeisi, Hadi Chavoshi, Maryam Mohammadi et al. (6 authors)
Process Biochemistry
Published: May 2019
55 citations
55 citations
2051 days before retraction
Quick Stats
Total Citations:
21
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Never